NIH Shrinks Tumors with Immunotherapy, ADHD Medications Show Benefits Over Risks, Scientists Decode E. coli Toxin, Study Urges Climate Model Overhaul, and more...

NIH Breakthrough: Personalized Immunotherapy Shrinks Tumors in GI Cancer Patients Amid Staffing ChallengesStudy Finds ADHD Medications' Benefits Outweigh Cardiovascular Risks Amid Rising PrescriptionsScientists Decode E. coli's Deadly Toxin, Paving Way for Targeted Treatments Amid Antibiotic ResistanceStudy Reveals Aerosols' Cooling Effect on Climate Greater Than Expected, Urges Climate Model OverhaulStudy Unveils Thalamus's Key Role in Conscious Awareness, Challenging Traditional Cortex-Centric ViewsTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news.